Get App Open
In App
Credit Cards
Open App
you are here:

UTI Healthcare Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : UTI Mutual Fund
  • NAV
    : ₹ 276.6986 -0.4%
    (as on 22nd January, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 97.58% investment in domestic equities of which 22.55% is in Large Cap stocks, 18.97% is in Mid Cap stocks, 18.9% in Small Cap stocks.The fund has 0.1% investment in Debt, of which 0.1% in Government securities.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 22nd January, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 15-Jan-25 9933.00 -0.67% - -0.98% 95/214
1 Month 20-Dec-24 9662.00 -3.38% - -4.79% 55/209
3 Month 22-Oct-24 9903.90 -0.96% - -5.99% 23/198
6 Month 22-Jul-24 11182.30 11.82% - -4.86% 8/186
YTD 01-Jan-25 9418.10 -5.82% - -5.18% 133/215
1 Year 19-Jan-24 13083.00 30.83% 30.45% 13.83% 5/162
2 Year 20-Jan-23 18772.40 87.72% 36.84% 23.64% 7/134
3 Year 21-Jan-22 17348.30 73.48% 20.12% 15.93% 31/124
5 Year 22-Jan-20 31352.80 213.53% 25.65% 19.83% 19/102
10 Year 22-Jan-15 31431.30 214.31% 12.12% 12.93% 45/73
Since Inception 30-Jul-05 152535.10 1425.35% 15.00% 11.55% 79/185

SIP Returns (NAV as on 22nd January, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 19-Jan-24 12000 13467.39 12.23 % 23.2 %
2 Year 20-Jan-23 24000 33653.3 40.22 % 36.13 %
3 Year 21-Jan-22 36000 55830.33 55.08 % 30.58 %
5 Year 22-Jan-20 60000 108491.11 80.82 % 23.88 %
10 Year 22-Jan-15 120000 298984.04 149.15 % 17.37 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Dec,2024)

Portfolio Turnover Ratio : 30.00%  |   Category average turnover ratio is 122.85%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 97.58% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 97.58%
No of Stocks : 42 (Category Avg - 44.26) | Large Cap Investments : 22.55%| Mid Cap Investments : 18.97% | Small Cap Investments : 18.9% | Other : 37.16%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 1367.6 11.07% 0.34% 13.91% (Feb 2024) 11.29% (Oct 2024) 7.25 L 0.00
- Cipla Ltd. Pharmaceuticals 710.9 5.75% 0.00% 7.77% (Feb 2024) 5.89% (Oct 2024) 4.65 L 14.29 k
Dr. Reddys Laboratories Ltd. Pharmaceuticals 652.9 5.28% 0.58% 6.69% (Nov 2023) 4.67% (Oct 2024) 4.70 L 0.00
Ajanta Pharma Limited Pharmaceuticals 566.1 4.58% -0.27% 5.95% (May 2024) 4.97% (Nov 2023) 1.93 L 0.00
Glenmark Pharmaceuticals Ltd. Pharmaceuticals 497.7 4.03% 0.10% 3.71% (Aug 2024) 0% (Nov 2023) 3.09 L 0.00
Gland Pharma Ltd. Pharmaceuticals 473.9 3.83% -0.02% 3.7% (Oct 2024) 2.5% (Nov 2023) 2.66 L 0.00
Apollo Hospitals Enterprises Ltd. Hospital 437.8 3.54% 0.13% 7.12% (Jan 2024) 3.55% (Oct 2024) 60.00 k 0.00
Fortis Healthcare Ltd. Hospital 401.5 3.25% -0.10% 4.59% (Nov 2023) 2.93% (Jul 2024) 5.58 L -0.54 L
Procter & Gamble Health Ltd. Pharmaceuticals 387.6 3.14% -0.04% 3.79% (Jun 2024) 1.95% (Jan 2024) 74.00 k 0.00
Divis Laboratories Ltd. Pharmaceuticals 375 3.03% -0.12% 3.38% (Nov 2023) 2.35% (Mar 2024) 61.48 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
No of Debt Holding 1 (Category Avg - 0.73) | Modified Duration 0.00 Years (Category Avg - 0.00)| Yield to Maturity - -- (Category Avg - 0.00%)

Type of Holdings

Security Type
% Weight
Category Average
GOI 0.00% 0.00%
T-Bills 0.10% 0.31%

Investment / Portfolio Grades

Security Type
% Weight
Category Average
Government Backed 0.10% 0.31%
Low Risk 0.00% 0.00%
Moderate Risk 0.00% 0.00%
High Risk 0.00% 0.00%
Very High Risk 0.00% 0.00%
Others 0.00% 0.00%
Name Type of Instrument Weight (%)
Net Receivables Net Receivables 2.31%
Margin Margin 0.01%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st December, 2024)

  • Standard Deviation

    Low volatility
    12.22vs14.98
    Category Avg
  • Beta

    Low volatility
    0.56vs0.84
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.97vs0.7
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.21vs0.12
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    8.37vs4.08
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth NA 5320.29 -2.34 -0.39 12.26 33.91 23.90
DSP Healthcare Fund - Regular Plan - Growth NA 3339.79 -0.44 0.28 14.54 32.32 22.36
LIC MF Healthcare Fund - Regular Plan - Growth NA 86.26 -3.25 -1.11 12.23 31.39 17.09
LIC MF Infrastructure Fund - Growth 4 927.50 -8.81 -4.89 -7.03 30.49 26.54
SBI Healthcare Opportunities Fund - Regular Plan - Growth NA 3628.03 -2.13 1.39 13.79 29.82 23.13
ITI Pharma & Healthcare Fund - Regular Plan - Growth NA 230.79 -4.42 -1.27 10.33 27.26 18.15
Kotak Healthcare Fund - Regular Plan - Growth NA 439.02 -3.83 0.15 10.62 27.23 0.00
Quant Commodities Fund - Regular Plan - Growth NA 427.02 -4.81 -6.68 -4.18 27.04 0.00
Tata India Pharma & Heathcare Fund - Growth NA 1287.45 -3.36 -1.74 8.35 26.90 20.49
Mirae Asset Healthcare Fund - Growth NA 2863.52 -3.09 -3.06 7.97 26.63 17.64

More Funds from UTI Mutual Fund

Out of 95 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 11 is/are ranked 4 * , 9 is/are ranked 3 * , 8 is/are ranked 2 * , 2 is/are ranked 1 * , and 62 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
UTI Nifty 50 ETF 4 57902.18 -1.74 -5.17 -5.09 8.49 10.77
UTI Nifty 50 ETF 4 57902.18 -1.74 -5.17 -5.09 8.49 10.77
UTI BSE Sensex ETF 5 44121.79 -2.08 -4.61 -4.73 8.10 10.28
UTI BSE Sensex ETF 5 44121.79 -2.08 -4.61 -4.73 8.10 10.28
UTI Flexi Cap Fund - Growth 1 26062.33 -4.97 -4.73 -1.70 11.64 4.88
UTI Liquid Fund - Regular Plan - Growth 2 23764.36 0.59 1.73 3.52 7.29 6.46
UTI Nifty 50 Index Fund - Growth 4 20010.28 -1.76 -5.23 -5.20 8.70 10.44
UTI Nifty 50 Index Fund - Growth 4 20010.28 -1.74 -5.16 -5.06 8.59 10.84
UTI Money Market Fund - Regular Plan - Growth 3 15370.41 0.63 1.77 3.65 7.63 6.74
UTI Large Cap Fund - Growth 2 12616.62 -1.83 -5.13 -5.27 9.45 8.57

Forum

+ See More

  翻译: